Due to improved diagnostic techniques, acoustic neuromas more frequently are detected at an early stage. Subsequent treatment depends on such factors as expected tumor growth rate, tumor size, and pa tient age. The natural history of acoustic neuromas is still uncertain:
INTRODUCTION
Diagnostic procedures to detect an acoustic neu roma have become much more sensitive since the introduction of brainstem evoked response audiome try, computed tomographic (CT) scanning, and mag netic resonance imaging, (MRI) which has further im proved sensitivity and specificity. These diagnostic procedures also are less difficult on patients than the previously used air cisternography. The newer diag nostic techniques have sometimes led to the unexpect ed diagnosis of an acoustic neuroma in patients with only slight symptoms. These visualization techniques have also made it possible for physicians to follow the growth of an acoustic neuroma before deciding whether surgical intervention is necessary. It has re cently been established that fairly small differences in the size of an acoustic neuroma can influence the oc currence of surgical complications.1
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Laryngoscope 105: July 1995 Since many acoustic neuromas now are followed using MRI, various questions have arisen about the natural history of these tumors. The most important questions concern the relationship between tumor growth rate, tumor size, and patient age. In addition, little is known about the distribution in individual growth rates. To answer these questions, it is neces sary to perform descriptive studies that focus on possi ble correlations between tumor size, signs and symp toms, and patient age.
From 1980 through 1992,164 patients underwent primary surgery for an acoustic neuroma at the Uni versity Hospital Nijmegen, The Netherlands. Using the diagnostic data recorded on these patients, the authors of this study examined correlations between tumor size, signs and symptoms, and patient age. Where possible, these findings were compared with those reported in a similar study that was performed in Copenhagen.2
MATERIALS AND METHODS
From 1980 through 1992, 258 operations for various types of space-occupying lesion in the cerebellopontine angle were conducted at the University Hospital Nijmegen. This study is based on the diagnostic data from the 164 patients who were operated on for an acoustic neuroma for the first time. In performing the surgeries, the suboccipital approach was used in 106 patients, the translabyrinthine, transotic, or combined approach was used in 56 patients, and the mid dle fossa approach was used in 2 patients. Excluded from the study were 36 patients who underwent a second surgery for an acoustic neuroma, 54 patients who were operated on for other histological diagnoses (N = 54), and 4 patients who were known to have central neurofibromatosis type I or II and a tumor in the cerebellopontine angle.
Tumor size was determined by a neuroradiologist. The maximum diameter of the total tumor was recorded, includ ing the intrameatal part. There was a good agreement be tween these values and those found during surgery. Data on patient sex, patient age at surgery, signs and symptoms, and duration of symptoms were collected from the medical files. The results of pure-tone audiometry and speech audiometry were also collected. In this way, it was possible to examine various correlations using linear regression lines between tumor size, patient sex, patient age, separate symptoms, du ration of symptoms, extent of hearing loss, and speech recog- van Unexplained perceptive asymmetry in the pure-tone audiogram was the most frequent reason for further otoneurological investigation. The maximum differences in percep tion for the frequencies 0.5,1.0,2.0, and 4.0 kHz were deter mined for the patients with a unilateral acoustic neuroma in order to establish the extent of asymmetry for at least one frequency. This approach gave a practical indication of the degree of asymmetry in the hearing loss. Certain levels of asymmetry may give rise to the suspicion of an acoustic neuroma. 
RESULTS
The study group included 88 women and 76 men, 17 to 79 years of age, with a mean age of 49.2 years. The majority of patients were between 40 and 60 years of age (Table I) The relationship between tumor size and patient age at surgery is presented in a scatter diagram (Fig.  2) . No significant correlation was found between tu mor size and patient age (N = 164, r = .0054, P = .49), since large and small tumors occurred in both young and older patients. Tb compare the findings of this study with those of the Copenhagen study,2 the tu mors were classified into the same three groups ac cording to size (i.e., 1 to 25 mm, 26 to 40 mm, and greater than 40 mm). The number of patients in each group is shown in Table II years of age. For each tumor size, the mean age and the male:female ratio were also determined ( Symptoms of an acoustic neuroma were divided into the presenting (main) symptom and all the symp toms in the history up to the time of surgery (Table IV) . The results reported in several other studies were in cluded for comparison.2> 5~7 The presenting symptom in the majority of cases was unilateral hearing loss. Less frequent presenting symptoms included tinnitus, vertigo, and facial paresthesia. Figure 3 shows an overview of the percentage of patients with various signs and symptoms per tumor size at the first otological consultation. Small tumors in particular were as sociated with hearing loss and tinnitus, while vertigo and otalgia were infrequent symptoms. Large tumors were associated with headaches, facial parasthesia, and ataxia, while eye symptoms and dysarthria were less frequent. These findings agreed with those report ed in the literature.11
When all the signs and symptoms were analyzed together, their incidence changed and other symp toms gained more importance (Table V) .5,s-io Vari ous symptoms were not always mentioned, including otalgia, sudden deafness, epilepsy, ataxia, nausea and vomiting, and dysarthria. In some studies, vertigo was recorded as a symptom, while in others it was sub classified into, for example, true vertigo, unsteadi ness, and dizziness. This made comparison of the inci dence impossible. Tumor size and the duration of the first symptom up to the diagnosis are presented in a scatter diagram in Figure 4 , The symptoms of small and large tumors were of both short and long dura tion. Therefore, there was no relationship at all be tween, for example, a long history of a symptom and (Table VI) , the majority of patients (51%) had a hearing loss of between 41 and 80 dB, irrespective of tumor size.
The difference in hearing thresholds between the affected ear and the normal ear was also assessed. The largest bone conducting difference was noted per fre quency, between 0.5 and 4.0 kHz. As shown in Table  VII , the mean asymmetry for one frequency was 57.7 dB (SD ± 23.1 dB). The patients in this study usuall* had asymmetrical hearing loss; in 95% of cases, ther * was at least a 20-dB difference for one of the frequen cies between 0.5 and 4,0 kHz.
A speech audiogram was available for 122 of the 164 patients. Maximum speech recognition scores were determined (Table VIII) . In Figure 6 , speech 
DISCUSSION
The fact that there was no clear relationship be tween tumor size, signs and symptoms, and the level of hearing loss means that even with optimal diagnos tic facilities, it is difficult to ensure that all tumors are detected in an early, small stage. In reviewing the rela tionships between tumor size, level of hearing loss, and patient age, the authors of this study found it striking that the expected correlations did not exist.
It would not have been surprising to find a relationship between tumor size and patient age or between tumor size and the level of hearing loss.
An acoustic neuroma can occur at almost any age, but most tumors are found in patients 40 to 60 years of age. In the present series, 75% of the patients were older than 40 years. In younger patients, the symp toms may be caused by central neurofibromatosis type II, which cannot always be recognized immediately.
The average age of the patients at surgery was similar in all series.2» 5"10
The size of the tumors operated on at the Uni versity Hospital Nijmegen decreased gradually over the time period of the study (Fig. 1) . The significant gradual decrease in mean tumor size per year, from 34 mm to 22 mm, is probably due to earlier consulta tion with a physician, improved diagnostic techniques, and increased awareness of the doctors. In particular, MRI has facilitated the early detection of small tu mors.
Other authors4'5 also have noted gradually de creasing tumor size at presentation in recent years. However, the opposite was reported in the Copen hagen study,2 which is representative of the whole of Denmark. The distribution of patients over the three age groups in the present study was very similar to that in the Copenhagen series. One striking difference was the number of patients with a tumor larger than 40 mm: 118 patients (33%) in the Copenhagen series versus 17 patients (10%) in the Nijmegen series. In view of the decrease in the number of large tumors found at various centers throughout the world, it may be appropriate to interpret the Copenhagen data cau tiously, particularly with regard to the existence of cor relations, because these correlations may be specific to the Danish patient population. External factors that influence the size of the tumors referred to a center may include, for example, the referral pattern in that particular region and the expertise of the surgeon.
An acoustic neuroma can occur at almost any age, and the tumor growth rate can vary greatly from indi vidual to individual.12
Little is known about the aver age growth rate and the distribution in the growth rates of acoustic tumors. Whether these tumors grow more slowly in older patients also is uncertain. If the growth rate remains fairly constant, larger tumors generally should be found in elderly patients. No large tumors were found in the elderly patients in the pres ent study. Various growth rates appear to be possible at all ages, and it seems likely that varying growth rates can occur in a single patient. Table III shows that the average age of patients with a large tumor de creased gradually, although not nonsignificantly, against time. However, this study found no correlation between tumor size and patient age (Fig. 2) .
It is possible that the growth rate varies, depend ing on whether the tumor has an isolated nongenetically determined etiology or an hereditary etiology, such as central neurofibromatosis type I or II. In light of recent genetic study results,13 it has become rea sonable to assume that a larger proportion of isolated cases of acoustic neuroma can be attributed to a chro mosomal defect than would be expected on the basis of Laryngoscope 105: July 1995 van Leeuwen, et ai.: Acoustic Neuroma clinical symptoms or family studies. Future gene ic studies may provide information that will help predict the expected growth rate of an acoustic neuroma.
The symptoms of an acoustic neuroma vaiy, and in a retrospective review it is not always possible to distinguish clearly between the presenting symptom and all the other symptoms. The presenting symp tom is usually unilateral deafness-but not in all cases. In addition, the percentage of patients with im paired hearing as their main symptom was found to decrease as tumor size increased (Fig. 3) . Therefore, tumor size appeared to influence the average com plaint pattern. Classifying the symptoms of an acous tic neuroma into an audiovestibular stage, a trigemi nal stage, or a brainstem stage is too absolute.11 It would be better to speak in terms of a gradual shift in symptoms (Fig, 3) . In the present study, no correlation was found between tumor size and the duration of symptoms (Fig. 4) . In fact, some of the patients with very short-term symptoms had large tumors, while some of the patients with long-term symptoms had tu mors that were mainly restricted to the intrameatal site. In contrast, the Copenhagen study2 reported a significant relationship between tumor size and symp tom duration {P < .05).
Wiegand and Fickel9 surveyed members of the American Acoustic Neuroma Association, Therefore, their study subjects were recruited using a procedure that was different from that employed in other studies He., subjects were members of a patient association as opposed to patients operated on by the authors of the study).
The incidence of hearing loss in the comparison studies (67% to 75%)2'5~7 was very similar to that in the present series. The symptom distribution in the oth er studies was higher for tinnitus (2% to 36%) and ver tigo (7% to 16%). Facial paresthesia was only observed in 1% to 3% of patients, while sudden deafness and headaches were not always mentioned. Some symp toms were mentioned infrequently in the literature. For instance, ataxia occurred in 33% of the patients in this series, but in only 8% of the patients in the study by Mathew, et a l.10 Symptoms such as sudden deafness occurred in only 3% to 4% of patients; however, in one study,14 sudden deafness was listed as the presenting symptom for small tumors in 19% of patients. If each of the possible symptoms of an acoustic neuroma were considered an indication for MRI, these tumors could be diagnosed much earlier. However, it is questionable whether the cost-benefit ratio would remain accept able in view of the number of negative diagnoses.
Unilateral hearing loss is the most frequent symptom of an acoustic neuroma, but no correlation was found between tumor size and the level of hearing loss. Deafness was found in patients with tumors of all sizes, but relatively good hearing could also be present on the affected side. Figure 5 shows that all combina tions of tumor size and hearing loss are possible. The Laryngoscope 105: July 1995 706 findings of this study disagreed with those in the Copenhagen study,2 which reported a relationship between tumor size and hearing loss for large tumors (P < ,001) .
The authors of the present study did find asym metry in the hearing loss of the pure-tone audiogram of at least 20 dB (average: 57.7 dB). Asymmetrical per ceptive hearing loss without any other symptoms is a strong indication for further otoneurological tests to look for an acoustic neuroma, even though a small pro portion of patients with such a tumor will have a nor mal pure-tone audiogram. These findings agree with those reported in a study performed in Seattle. 15 The authors of the Seattle study recommended that if the average threshold difference at 1 to 8 kHz was 20 dB or greater, MRI should be performed on the suspicion of an acoustic neuroma. Brainstem evoked response au diometry should suffice in patients with an average threshold difference of less than 20 dB.
CONCLUSION
Expected correlations among tumor size, symp toms, and patient age could not be demonstrated. Questions regarding tumor growth rate and the distri bution in growth rates remain unanswered. It is not possible to say whether there is a relationship be tween the moment that a tumor starts to develop and the age of the patient; symptoms do not give any reli able indication. Since the authors of the present study could not demonstrate any of the correlations formerly assumed to exist, it would seem appropriate not to base the answers to any remaining questions about variation in tumor growth rate and the age of the pa tient on similar provisional assumptions. This would obviously have consequences on otoneurological diag nosis and would necessitate repeated cost-benefit analyses. Tumor growth rate is still unknown and therefore remains a problem in designing the treat ment plan for a patient with an acoustic neuroma. BIBLIOGRAPHY 
